Thursday, December 14, 2017 11:28:10 AM
Like I said before, I bought a little bit more at .19, but only an amount I am willing to lose. 5 years ago, this company looked so promising. It really is sad to see how poorly it has been run considering its potential. Unless they have been lying to us, the technology can literally save countless lives. A competent leader would have a product in the market by now and would be generating revenue to fund further R&D and FDA approvals.
Recent BPTH News
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 07/11/2025 08:44:58 PM
- Life Sciences Investor Forum: Now Available for Online Viewing • GlobeNewswire Inc. • 06/13/2025 12:35:00 PM
- Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum • GlobeNewswire Inc. • 06/09/2025 11:00:00 AM
- Bio-Path Holdings Provides Clinical and Operational Update • GlobeNewswire Inc. • 06/03/2025 11:00:00 AM
- Form 253G3 - • Edgar (US Regulatory) • 06/02/2025 08:35:21 PM
